Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure

Liqiang Chen, Riccardo Petrelli, Guangyao Gao, Daniel J. Wilson, Garrett T. McLean, Hiremagalur N. Jayaram, Yuk Y. Sham, Krzysztof W. Pankiewicz

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Small molecules that act on multiple biological targets have been proposed to combat the drug resistance commonly observed for cancer chemotherapy. By combining the structural features of known inhibitors of inosine monophosphate dehydrogense (IMPDH) and histone deacetylase (HDAC), dual inhibitors of IMPDH and HDAC based on the scaffold of cinnamic hydroxamic acid (CHA) have been designed, synthesized, and evaluated in biological assays. Key features, including the linker length, linker functionality, substitution position, and interacting groups, have been explored. Their individual contribution to the inhibitory activities against human IMPDH1 and IMPDH2 as well as HDAC has been assessed.

Original languageEnglish
Pages (from-to)5950-5964
Number of pages15
JournalBioorganic and Medicinal Chemistry
Volume18
Issue number16
DOIs
StatePublished - Aug 15 2010

Fingerprint

Hydroxamic Acids
Inosine Monophosphate
Histone Deacetylases
Oxidoreductases
Histone Deacetylase Inhibitors
Drug Resistance
Human Activities
Biological Assay
Chemotherapy
Scaffolds
Drug Therapy
Assays
Substitution reactions
Neoplasms
Molecules
Pharmaceutical Preparations
cinnamic acid

Keywords

  • Cancer therapy
  • Cinnamic hydroxamic acid
  • Drug resistance
  • Dual inhibitor
  • Histone deacetylase
  • Inosine monophosphate dehydrogenase

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure. / Chen, Liqiang; Petrelli, Riccardo; Gao, Guangyao; Wilson, Daniel J.; McLean, Garrett T.; Jayaram, Hiremagalur N.; Sham, Yuk Y.; Pankiewicz, Krzysztof W.

In: Bioorganic and Medicinal Chemistry, Vol. 18, No. 16, 15.08.2010, p. 5950-5964.

Research output: Contribution to journalArticle

Chen, L, Petrelli, R, Gao, G, Wilson, DJ, McLean, GT, Jayaram, HN, Sham, YY & Pankiewicz, KW 2010, 'Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure', Bioorganic and Medicinal Chemistry, vol. 18, no. 16, pp. 5950-5964. https://doi.org/10.1016/j.bmc.2010.06.081
Chen, Liqiang ; Petrelli, Riccardo ; Gao, Guangyao ; Wilson, Daniel J. ; McLean, Garrett T. ; Jayaram, Hiremagalur N. ; Sham, Yuk Y. ; Pankiewicz, Krzysztof W. / Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure. In: Bioorganic and Medicinal Chemistry. 2010 ; Vol. 18, No. 16. pp. 5950-5964.
@article{1586591eebf74209b427a52b92559e36,
title = "Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure",
abstract = "Small molecules that act on multiple biological targets have been proposed to combat the drug resistance commonly observed for cancer chemotherapy. By combining the structural features of known inhibitors of inosine monophosphate dehydrogense (IMPDH) and histone deacetylase (HDAC), dual inhibitors of IMPDH and HDAC based on the scaffold of cinnamic hydroxamic acid (CHA) have been designed, synthesized, and evaluated in biological assays. Key features, including the linker length, linker functionality, substitution position, and interacting groups, have been explored. Their individual contribution to the inhibitory activities against human IMPDH1 and IMPDH2 as well as HDAC has been assessed.",
keywords = "Cancer therapy, Cinnamic hydroxamic acid, Drug resistance, Dual inhibitor, Histone deacetylase, Inosine monophosphate dehydrogenase",
author = "Liqiang Chen and Riccardo Petrelli and Guangyao Gao and Wilson, {Daniel J.} and McLean, {Garrett T.} and Jayaram, {Hiremagalur N.} and Sham, {Yuk Y.} and Pankiewicz, {Krzysztof W.}",
year = "2010",
month = "8",
day = "15",
doi = "10.1016/j.bmc.2010.06.081",
language = "English",
volume = "18",
pages = "5950--5964",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "16",

}

TY - JOUR

T1 - Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure

AU - Chen, Liqiang

AU - Petrelli, Riccardo

AU - Gao, Guangyao

AU - Wilson, Daniel J.

AU - McLean, Garrett T.

AU - Jayaram, Hiremagalur N.

AU - Sham, Yuk Y.

AU - Pankiewicz, Krzysztof W.

PY - 2010/8/15

Y1 - 2010/8/15

N2 - Small molecules that act on multiple biological targets have been proposed to combat the drug resistance commonly observed for cancer chemotherapy. By combining the structural features of known inhibitors of inosine monophosphate dehydrogense (IMPDH) and histone deacetylase (HDAC), dual inhibitors of IMPDH and HDAC based on the scaffold of cinnamic hydroxamic acid (CHA) have been designed, synthesized, and evaluated in biological assays. Key features, including the linker length, linker functionality, substitution position, and interacting groups, have been explored. Their individual contribution to the inhibitory activities against human IMPDH1 and IMPDH2 as well as HDAC has been assessed.

AB - Small molecules that act on multiple biological targets have been proposed to combat the drug resistance commonly observed for cancer chemotherapy. By combining the structural features of known inhibitors of inosine monophosphate dehydrogense (IMPDH) and histone deacetylase (HDAC), dual inhibitors of IMPDH and HDAC based on the scaffold of cinnamic hydroxamic acid (CHA) have been designed, synthesized, and evaluated in biological assays. Key features, including the linker length, linker functionality, substitution position, and interacting groups, have been explored. Their individual contribution to the inhibitory activities against human IMPDH1 and IMPDH2 as well as HDAC has been assessed.

KW - Cancer therapy

KW - Cinnamic hydroxamic acid

KW - Drug resistance

KW - Dual inhibitor

KW - Histone deacetylase

KW - Inosine monophosphate dehydrogenase

UR - http://www.scopus.com/inward/record.url?scp=77955466735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955466735&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2010.06.081

DO - 10.1016/j.bmc.2010.06.081

M3 - Article

C2 - 20650640

AN - SCOPUS:77955466735

VL - 18

SP - 5950

EP - 5964

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 16

ER -